Industry News
Nominations open for 2010 Victoria Prize and Fellowships
Applications open today for over $150,000 in prizes and fellowships. [ + ]
Stirling snaps up Canadian drug manufacturing plant for a song
$20 million state-of-the-art manufacturing facility acquired for $3.85 million. [ + ]
Bionomics announces positive results in phase Ia trial of anti-stress drug
Final results of phase Ia trial of BNC210 announced demonstrating safety and efficacy. [ + ]
HalcyGen sees success in SUBA-Itraconazole study
Preliminary results look good in clinical pharmacokinetic study comparing SUBA-Itraconazole with Sporanox. [ + ]
Feature: Appetite for NPY
A better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system. [ + ]
BioProspect consolidates deal with Solagran
Solagran and BioProspect to develop commercialisation plan for animal health and nutrition products. [ + ]
Monash University researchers cotton on to lab-on-a-chip enhancement
A discovery by Monash University scientists could see humble cotton thread emerge as a core material in low-cost ‘lab-on-chip’ devices capable of detecting diseases such as kidney failure and diabetes.
[ + ]Epilepsy, aging and malaria research big winners in 2010 NHMRC grants
$102 million in NHMRC grants target epilepsy, malaria, melanoma, pain, infant health, medical tests, infection, aging, Indigenous health and stuttering. [ + ]
Patrys granted key patent for lead anti-cancer product
Issued patent for lead product PAT-CM1 provides protection through the year 2023. [ + ]
Biotech Market Spotlight: HealthLinx
UPDATED: Release of OvPlex ovarian cancer test in UK sends shares soaring. [ + ]
MicroRNA causes "double whammy" of metastasis and angiogenesis in breast cancer
New research shows the microRNA, miR-9, plays a significant role in metastasis and blood vessel growth in breast cancer and could provide a target for future therapies. [ + ]
Comments sought on $52m research collaboration program
The federal government has released a discussion paper on the Collaborative Research Networks (CRN) program - the first of its kind in Australia - which will provide $52 million from 2011 to promote mutually beneficial collaboration between universities.
[ + ]Epigenetics makes cancer cell "lean mean machine"
Garvan researchers find gene silencing in prostate cancer is more substantial than expected and could provide key to battling cancer. [ + ]
$38m to get new technologies working for Australia
The National Enabling Technologies Strategy has been released. The strategy provides a comprehensive national framework to guide the development of new technologies.
[ + ]New invention set to unlock environmental secrets
IRMS++, invented by Dr Mike Hotchkis and Dr Chris Waring at the Australian Nuclear Science and Technology Organisation, uses a newly developed, patented microwave-driven plasma source to generate large signals directly from very small volumes of liquid or gas for measurement of their isotopic composition.
[ + ]